|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0040223,
umls-concept:C0138741,
umls-concept:C0194810,
umls-concept:C0205210,
umls-concept:C0205474,
umls-concept:C0231174,
umls-concept:C0376358,
umls-concept:C0449258,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1705764,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-6-6
|
|
pubmed:abstractText |
To characterize the clinical progression of disease in men who have undergone prostatectomy for clinically localized prostate cancer and have postoperative biochemical failure (elevated prostate-specific antigen [PSA] level) and to identify predictors of clinical disease progression, including the possible effect of PSA doubling time (PSADT).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0025-6196
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
576-81
|
|
pubmed:dateRevised |
2007-10-29
|
|
pubmed:meshHeading |
pubmed-meshheading:11393495-Analysis of Variance,
pubmed-meshheading:11393495-Biopsy,
pubmed-meshheading:11393495-Disease Progression,
pubmed-meshheading:11393495-Disease-Free Survival,
pubmed-meshheading:11393495-Follow-Up Studies,
pubmed-meshheading:11393495-Humans,
pubmed-meshheading:11393495-Linear Models,
pubmed-meshheading:11393495-Lymph Node Excision,
pubmed-meshheading:11393495-Male,
pubmed-meshheading:11393495-Neoplasm Recurrence, Local,
pubmed-meshheading:11393495-Neoplasm Staging,
pubmed-meshheading:11393495-Palpation,
pubmed-meshheading:11393495-Ploidies,
pubmed-meshheading:11393495-Predictive Value of Tests,
pubmed-meshheading:11393495-Proportional Hazards Models,
pubmed-meshheading:11393495-Prostate-Specific Antigen,
pubmed-meshheading:11393495-Prostatectomy,
pubmed-meshheading:11393495-Prostatic Neoplasms,
pubmed-meshheading:11393495-Risk Factors,
pubmed-meshheading:11393495-Severity of Illness Index,
pubmed-meshheading:11393495-Time Factors,
pubmed-meshheading:11393495-Tumor Markers, Biological,
pubmed-meshheading:11393495-Ultrasonography
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
|
|
pubmed:affiliation |
Department of Urology, Mayo Clinic, Rochester, Minn 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Validation Studies
|
